Capital International Investors Portfolio holdings
Capital International, established in 1968 as a division of the Los Angeles-based Capital Group, is a global investment management firm focused on delivering equity investment solutions for institutional and individual clients worldwide. Operating as part of one of the oldest and largest asset managers, founded in 1931, it leverages Capital Group’s signature research-driven, long-term investment philosophy, managing billions in assets through a multi-manager system that diversifies risk and enhances performance. Headquartered in Los Angeles with a presence across North America, Europe, and Asia, Capital International specializes in international and global equity strategies, often through mutual funds like those in the American Funds family. Known for its rigorous fundamental analysis and commitment to client outcomes, it plays a key role in Capital Group’s mission to provide consistent, superior returns in global markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$1.19B |
| 2 |
CVS Health
CVS
|
+$803M |
| 3 |
Microsoft
MSFT
|
+$678M |
| 4 |
Amazon
AMZN
|
+$659M |
| 5 |
Vale
VALE
|
+$577M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Corpay
CPAY
|
+$1.17B |
| 2 |
Booking.com
BKNG
|
+$882M |
| 3 |
Truist Financial
TFC
|
+$518M |
| 4 |
ConocoPhillips
COP
|
+$498M |
| 5 |
Merck
MRK
|
+$436M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.2% |
| 2 | Communication Services | 15.23% |
| 3 | Financials | 14.97% |
| 4 | Healthcare | 13.69% |
| 5 | Industrials | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
UFP Industries
UFPI
$5.06B
| $22.4M | 0.01% |
301,905
+198,561
| +192% | +$15.7M |
|
|
DNMR
402
DELISTED
Danimer Scientific, Inc.
DNMR
| $22.3M | 0.01% |
22,243
-42
| -0.2% | -$41.9K |
|
403
Insulet
PODD
$10.1B
| $21.4M | ﹤0.01% |
77,900
| – | – |
|
|
SAND
404
DELISTED
Sandstorm Gold
SAND
| $20.8M | ﹤0.01% |
2,639,868
+1,278,568
| +94% | +$10.4M |
|
|
CLLS
405
Cellectis
CLLS
$296M
| $20.7M | ﹤0.01% |
1,339,336
| – | – |
|
|
EAR
406
DELISTED
Eargo, Inc. Common Stock
EAR
| $20.7M | ﹤0.01% |
25,896
+10,313
| +66% | +$8.65M |
|
407
Xenon Pharmaceuticals
XENE
$6.31B
| $19.7M | ﹤0.01% |
1,055,726
| – | – |
|
408
GoodRx Holdings
GDRX
$1.22B
| $19.4M | ﹤0.01% |
539,771
-23,465
| -4% | -$866K |
|
409
Monster Beverage
MNST
$90.1B
| $18.3M | ﹤0.01% |
801,696
+1,060
| +0.1% | +$24.9K |
|
410
Seer Inc
SEER
$118M
| $17.9M | ﹤0.01% |
544,694
-71,857
| -12% | -$2.83M |
|
411
Schrodinger
SDGR
$1.39B
| $17.5M | ﹤0.01% |
232,084
| – | – |
|
412
Hamilton Lane
HLNE
$5.69B
| $17.2M | ﹤0.01% |
+188,760
| New | +$17.1M |
|
413
Coca-Cola
KO
$373B
| $15.8M | ﹤0.01% |
291,465
-713
| -0.2% | -$38.8K |
|
414
Aveanna Healthcare
AVAH
$1.97B
| $15.4M | ﹤0.01% |
+1,246,000
| New | +$14.8M |
|
415
Fair Isaac
FICO
$22.6B
| $14.6M | ﹤0.01% |
29,100
| – | – |
|
|
GRCL
416
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
| $14.6M | ﹤0.01% |
1,122,533
| – | – |
|
|
KRON
417
DELISTED
Kronos Bio
KRON
| $14.4M | ﹤0.01% |
600,000
| – | – |
|
418
MarketAxess Holdings
MKTX
$5.72B
| $13.5M | ﹤0.01% |
29,200
| – | – |
|
419
iShares MSCI EAFE ETF
EFA
$80.2B
| $13.1M | ﹤0.01% |
164,954
-110,862
| -40% | -$8.81M |
|
|
ADAG
420
Adagene
ADAG
$248M
| $12.5M | ﹤0.01% |
923,269
| – | – |
|
|
NCNA
421
NuCana
NCNA
$5.95M
| $12.2M | ﹤0.01% |
883
| – | – |
|
|
FYBR
422
DELISTED
Frontier Communications
FYBR
| $11.6M | ﹤0.01% |
+439,057
| New | +$11.1M |
|
|
AYX
423
DELISTED
Alteryx Inc
AYX
| $11.4M | ﹤0.01% |
133,000
| – | – |
|
424
iShares Core S&P 500 ETF
IVV
$904B
| $11.1M | ﹤0.01% |
25,890
+2,814
| +12% | +$1.18M |
|
425
Berkshire Hathaway Class A
BRK.A
$1.09T
| $10.9M | ﹤0.01% |
26
-18
| -41% | -$7.57M |
|
Similar funds
Capital International Investors's Q2 2021 Portfolio in Review
As of Q2 2021, Capital International Investors held 471 positions worth $438B, up 11% from $395B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Capital International Investors's Q2 2021 filing shows 32 new, 241 increased, 125 reduced and 23 closed positions. Its largest new stake was Strategy Inc: 9,532,420 shares worth $633M. The largest sale was Corpay, an estimated $1.17B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Communication Services and Financials.
- Capital International Investors's largest Q2 2021 buy was Strategy Inc: 9,532,420 shares worth $633M.
- Capital International Investors added most to Netflix in Q2 2021, an estimated $1.19B increase.
- Capital International Investors's biggest Q2 2021 reduction was Corpay, cutting an estimated $1.17B.
- Capital International Investors fully exited Public Service Enterprise Group in Q2 2021, selling an estimated $147M.
- Capital International Investors's ten largest holdings make up 29% of its $438B portfolio in Q2 2021.
- Capital International Investors opened 32 new positions and closed 23 in Q2 2021.
- Capital International Investors's portfolio value rose 11% quarter-over-quarter to $438B.
Based on Capital International Investors's 13F filing for Q2 2021, filed 16 Aug 2021.